These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10790998)

  • 1. [Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
    Kitamura M; Arai K; Iwasaki Y; Takahashi T; Saitoh K; Fujii T; Shirasaka T
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):559-63. PubMed ID: 10790998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of rectal cancer with liver and pulmonary metastases responding to TS-1].
    Nishimura G; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1453-6. PubMed ID: 11681257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
    Shirasaka T; Yamamitsu S; Tsuji A; Terashima M; Hirata K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):832-45. PubMed ID: 10897209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.
    Yamagata S; Nakata B; Hirakawa K
    Oncol Rep; 2004 Nov; 12(5):973-8. PubMed ID: 15492780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.
    Peters GJ; Noordhuis P; Van Kuilenburg AB; Schornagel JH; Gall H; Turner SL; Swart MS; Voorn D; Van Gennip AH; Wanders J; Holwerda U; Smid K; Giaccone G; Fumoleau P; Van Groeningen CJ
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):1-12. PubMed ID: 12739060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial response of liver metastasis from colon cancer following intermittent oral administration of TS-1 after intra-hepatic arterial single injection of CDDP, doxorubicin and 5-FU].
    Oguro A; Nanri M; Miyamoto Y; Ujiie K; Iitaka D; Suzuki T; Koh T; Kobayashi S; Yamazaki J
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1669-71. PubMed ID: 17108740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of S-1 on DMH induced colon cancer in rats.
    Tsunoda A; Shibusawa M; Tsunoda Y; Yokoyama N; Nakao K; Kusano M; Nomura N; Nagayama S; Takechi T
    Anticancer Res; 1998; 18(2A):1137-41. PubMed ID: 9615778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.
    Tominaga K; Higuchi K; Okazaki H; Suto R; Hamaguchi M; Tanigawa T; Sasaki E; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Arakawa T
    Oncology; 2004; 66(5):358-64. PubMed ID: 15331922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
    Terakura M; Kaneko M; Ikebe T; Yoshioka H; Tanaka H
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):645-7. PubMed ID: 18408436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma.
    Konno H; Tanaka T; Baba M; Kanai T; Matsumoto K; Kamiya K; Nakamura S
    Jpn J Cancer Res; 1999 Apr; 90(4):448-53. PubMed ID: 10363584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
    Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
    Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
    Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic.
    Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():193-205. PubMed ID: 10895155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three successful case reports of advanced gastric cancer with chemotherapy].
    Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
    Tokuhara T; Hara A; Takahashi Y; Harada T; Izumi N; Iwamoto S; Satake K
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):917-9. PubMed ID: 15222112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
    Baba H; Yamamoto M; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T
    Gastric Cancer; 2003; 6 Suppl 1():45-9. PubMed ID: 12775020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
    Harada K; Kawaguchi S; Supriatno ; Onoue T; Yoshida H; Sato M
    Oral Oncol; 2004 Aug; 40(7):713-9. PubMed ID: 15172641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.